The leading cause of gynecological cancer-related morbidity and mortality is ovarian cancer (OC), which is dubbed a silent killer. Currently, OC is a target of intense biomarker research, because it is often not discovered until the disease is advanced. The goal of OC research is to develop effective tests using biomarkers that can detect the disease at the earliest stages, which would eventually decrease the mortality, thereby preventing recurrence. Therefore, there is a pressing need to revisit the existing biomarkers to recognize the potential biomarkers that can lead to efficient predictors for the OC diagnosis. This Perspective covers an update on the currently available biomarkers used in the triaging of OC to gain certain insights into the potential role of these biomarkers and their estimation that are crucial to the understanding of neoplasm progression, diagnostics, and therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acsbiomaterials.2c00390 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Decoding Brain Development and Aging: Pioneering Insights From MRI Techniques.
Invest Radiol
October 2024
From the Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan (A.H., S.K., J.K., M.N., W.U., S.F., T.A., A.W., K.K., S.A.); Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan (A.H., M.N., S.F.); Polytechnique Montréal, Montreal, Quebec, Canada (S.N.); Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada (S.N.); and Center for Advanced Interdisciplinary Research, Ss. Cyril and Methodius University in Skopje, Skopje, North Macedonia (S.N.).
The aging process induces a variety of changes in the brain detectable by magnetic resonance imaging (MRI). These changes include alterations in brain volume, fluid-attenuated inversion recovery (FLAIR) white matter hyperintense lesions, and variations in tissue properties such as relaxivity, myelin, iron content, neurite density, and other microstructures. Each MRI technique offers unique insights into the structural and compositional changes occurring in the brain due to normal aging or neurodegenerative diseases.
View Article and Find Full Text PDFCurrent opinions: updates on the changing landscape in the management of cervical cancer.
Curr Opin Obstet Gynecol
September 2024
Jonsson Comprehensive Cancer Center, University of California.
Purpose Of Review: To review the recent updates in the management of cervical cancer across all stages of the disease.
Recent Findings: After decades of minor advances, the landscape in cervical cancer is now rapidly changing. Recent studies have reported across the cervical cancer spectrum and on different therapeutic modalities.
Blood-Based Biomarkers and Risk of Onset of Mild Cognitive Impairment Over the Short and Long Term.
Neurology
January 2025
Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Background And Objectives: Blood-based biomarkers of amyloid and tau have been shown to predict Alzheimer disease (AD) dementia. Much less is known about their ability to predict risk of mild cognitive impairment (MCI), an earlier disease stage. This study examined whether levels of blood biomarkers of amyloid (Aβ/Aβ ratio), tau (p-tau), neurodegeneration (NfL), and glial activation and neuroinflammation (glial fibrillary acidic protein [GFAP], YKL40, soluble triggering receptor expressed on myeloid cells 2 [sTREM2]) collected when participants were cognitively normal are associated with the time to onset of MCI.
View Article and Find Full Text PDFDeveloping a 3D bone model of osteosarcoma to investigate cancer mechanisms and evaluate treatments.
FASEB J
December 2024
Antibody and Vaccine Group, Faculty of Medicine, Centre for Cancer Immunology, School of Cancer Sciences, University of Southampton, Southampton, UK.
Osteosarcoma is the most common primary bone cancer, occurring frequently in children and young adults. Patients are treated with surgery and multi-agent chemotherapy, and despite the introduction of mifamurtide in 2011, there has been little improvement in survival for decades. 3-dimensional models offer the potential to understand the complexity of the osteosarcoma tumor microenvironment and aid in developing new treatment approaches.
View Article and Find Full Text PDFIdentification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma.
Clin Transl Med
December 2024
Department of Urology, The Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!